ClinConnect ClinConnect Logo
Search / Trial NCT05050201

Implementation of Digital CBT for Insomnia in First Episode Psychosis

Launched by NHS GREATER GLASGOW AND CLYDE · Sep 17, 2021

Trial Information

Current as of May 17, 2025

Unknown status

Keywords

Insomnia Psychosis First Episode Psychosis Digital Cbt Cbt I

ClinConnect Summary

First episode psychosis (FEP) services present a unique opportunity to effect change in outcomes in those affected by experiences of psychosis. Sleep disorder, particularly insomnia, is common in those affected by psychosis, including those experiencing a first episode and are associated with increased symptomatology. Mood and worry mediate the relationship between sleep and psychosis symptomatology and research suggests that improving sleep in this population can improve mental health symptomatology and longer term outcomes. Cognitive Behavioural Therapy is effective in treating insomnia (...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Service users under the care of Esteem First Episode Psychosis Service in NHS GGC
  • Potentially affected by Insomnia Disorder (defined by Sleep Condition Indicator-02 score ≤2)
  • Who have access to a device they can use Sleepio on (a computer device with Safari or Google Chrome browser, or an iPhone device).
  • Exclusion Criteria:
  • Moderate to severe learning disability
  • Acute Psychosis (recent crisis contact or hospitalisation)
  • Incapacity to provide informed consent
  • Insufficient English to access intervention
  • Organic impairment
  • No access to a device which can be used for Sleepio intervention.

About Nhs Greater Glasgow And Clyde

NHS Greater Glasgow and Clyde (NHS GG&C) is one of the largest health organizations in the UK, dedicated to delivering high-quality healthcare services to a diverse population. As a clinical trial sponsor, NHS GG&C plays a pivotal role in advancing medical research and improving patient outcomes through innovative clinical studies. The organization is committed to upholding rigorous ethical standards and regulatory compliance, ensuring that all trials are conducted with the utmost care for participant safety and scientific integrity. With a focus on collaboration, NHS GG&C partners with academic institutions, healthcare professionals, and industry stakeholders to foster an environment conducive to groundbreaking research and the development of new therapies.

Locations

Glasgow, , United Kingdom

Glasgow, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Andrew Gumley

Principal Investigator

NHS Greater Glasgow and Clyde; University of Glasgow

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials